Gabelli & Co Investment Advisers’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio OPTR Stock Details OPTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-796,617	Closed	-$10M	–	155
2013 Q3	$10M	Buy	+796,617	New	+$10.6M	2.18%	13

Gabelli & Co Investment Advisers's OPTR Position: Q4 2013 in Review

Gabelli & Co Investment Advisers sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 796,617 shares — an estimated $10M sold.

Gabelli & Co Investment Advisers first reported a position in OPTR in Q3 2013 and held it in 1 quarter. The position peaked at $10M in Q3 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

Gabelli & Co Investment Advisers reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 796,617 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $10M.
Gabelli & Co Investment Advisers first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q3 2013 and held it in 1 quarter.
Gabelli & Co Investment Advisers's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $10M in Q3 2013.
0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on Gabelli & Co Investment Advisers's 13F filing for Q4 2013, filed 7 Feb 2014.